Skip to main content

Peer Review reports

From: A real-world disproportionality analysis of the US Food and Drug Administration (FDA) adverse event reporting system (FAERS) events for Durvalumab

Original Submission
12 Sep 2024 Submitted Original manuscript
18 Sep 2024 Author responded Author comments - Yusi Hua
Resubmission - Version 2
18 Sep 2024 Submitted Manuscript version 2
6 Oct 2024 Reviewed Reviewer Report - Mohamed Eltokhy
6 Oct 2024 Reviewed Reviewer Report
7 Oct 2024 Reviewed Reviewer Report - Shadan Modaresahmadi
14 Oct 2024 Reviewed Reviewer Report
3 Nov 2024 Author responded Author comments - Yusi Hua
Resubmission - Version 3
3 Nov 2024 Submitted Manuscript version 3
22 Nov 2024 Reviewed Reviewer Report
27 Nov 2024 Reviewed Reviewer Report
27 Nov 2024 Reviewed Reviewer Report - Mohamed Eltokhy
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Dec 2024 Editorially accepted
18 Dec 2024 Article published 10.1186/s40360-024-00821-y

You can find further information about peer review here.

Back to article page